About the Company
We do not have any company description for Iterum Therapeutics plc at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ITRM News
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn’t one of the ...
Iterum Therapeutics plc (ITRM)
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02.
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
--Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE ...
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript
Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings ...
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV ...
Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript
Hello, everyone, and welcome to the Iterum Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Business Update. My name is Emily, and I'll be coordinating your call today.
Iterum Therapeutics PLC ITRM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Iterum Therapeutics PLC: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to ...
Q4 2023 Iterum Therapeutics PLC Earnings Call
Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call. (Operator ...
Q4 2023 Iterum Therapeutics PLC Earnings Call
Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call. (Operator ...
Loading the latest forecasts...